152 related articles for article (PubMed ID: 33629858)
1. Design of Thioether Cyclic Peptide Scaffolds with Passive Permeability and Oral Exposure.
Golosov AA; Flyer AN; Amin J; Babu C; Gampe C; Li J; Liu E; Nakajima K; Nettleton D; Patel TJ; Reid PC; Yang L; Monovich LG
J Med Chem; 2021 Mar; 64(5):2622-2633. PubMed ID: 33629858
[TBL] [Abstract][Full Text] [Related]
2. Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure.
Fouché M; Schäfer M; Berghausen J; Desrayaud S; Blatter M; Piéchon P; Dix I; Martin Garcia A; Roth HJ
ChemMedChem; 2016 May; 11(10):1048-59. PubMed ID: 27154275
[TBL] [Abstract][Full Text] [Related]
3. Membrane Permeability in a Large Macrocyclic Peptide Driven by a Saddle-Shaped Conformation.
Faris JH; Adaligil E; Popovych N; Ono S; Takahashi M; Nguyen H; Plise E; Taechalertpaisarn J; Lee HW; Koehler MFT; Cunningham CN; Lokey RS
J Am Chem Soc; 2024 Feb; 146(7):4582-4591. PubMed ID: 38330910
[TBL] [Abstract][Full Text] [Related]
4. Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry.
Furukawa A; Townsend CE; Schwochert J; Pye CR; Bednarek MA; Lokey RS
J Med Chem; 2016 Oct; 59(20):9503-9512. PubMed ID: 27690434
[TBL] [Abstract][Full Text] [Related]
5. cis-Peptide Bonds: A Key for Intestinal Permeability of Peptides? .
Marelli UK; Ovadia O; Frank AO; Chatterjee J; Gilon C; Hoffman A; Kessler H
Chemistry; 2015 Oct; 21(43):15148-52. PubMed ID: 26337831
[TBL] [Abstract][Full Text] [Related]
6. Cell-permeable cyclic peptides from synthetic libraries inspired by natural products.
Hewitt WM; Leung SS; Pye CR; Ponkey AR; Bednarek M; Jacobson MP; Lokey RS
J Am Chem Soc; 2015 Jan; 137(2):715-21. PubMed ID: 25517352
[TBL] [Abstract][Full Text] [Related]
7. Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone
Li Y; Li W; Xu Z
Mar Drugs; 2021 May; 19(6):. PubMed ID: 34072121
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
9. Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides.
Wang S; König G; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2021 Sep; 64(17):12761-12773. PubMed ID: 34406766
[TBL] [Abstract][Full Text] [Related]
10. On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds.
White TR; Renzelman CM; Rand AC; Rezai T; McEwen CM; Gelev VM; Turner RA; Linington RG; Leung SS; Kalgutkar AS; Bauman JN; Zhang Y; Liras S; Price DA; Mathiowetz AM; Jacobson MP; Lokey RS
Nat Chem Biol; 2011 Sep; 7(11):810-7. PubMed ID: 21946276
[TBL] [Abstract][Full Text] [Related]
11. Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products.
Bockus AT; Lexa KW; Pye CR; Kalgutkar AS; Gardner JW; Hund KC; Hewitt WM; Schwochert JA; Glassey E; Price DA; Mathiowetz AM; Liras S; Jacobson MP; Lokey RS
J Med Chem; 2015 Jun; 58(11):4581-9. PubMed ID: 25950816
[TBL] [Abstract][Full Text] [Related]
12. The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides.
Ovadia O; Greenberg S; Chatterjee J; Laufer B; Opperer F; Kessler H; Gilon C; Hoffman A
Mol Pharm; 2011 Apr; 8(2):479-87. PubMed ID: 21375270
[TBL] [Abstract][Full Text] [Related]
13. Enantiomeric cyclic peptides with different Caco-2 permeability suggest carrier-mediated transport.
Marelli UK; Bezençon J; Puig E; Ernst B; Kessler H
Chemistry; 2015 May; 21(22):8023-7. PubMed ID: 25917866
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Studies around the Mono- and Difunctionalization of a Bioavailable Cyclic Decapeptide Scaffold.
Fouché M; Schäfer M; Blatter M; Berghausen J; Desrayaud S; Roth HJ
ChemMedChem; 2016 May; 11(10):1060-8. PubMed ID: 27094987
[TBL] [Abstract][Full Text] [Related]
15. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.
Matsui K; Kido Y; Watari R; Kashima Y; Yoshida Y; Shuto S
Chemistry; 2017 Mar; 23(13):3034-3041. PubMed ID: 27878880
[TBL] [Abstract][Full Text] [Related]
16. Large Libraries of Structurally Diverse Macrocycles Suitable for Membrane Permeation.
Nielsen AL; Bognar Z; Mothukuri GK; Zarda A; Schüttel M; Merz ML; Ji X; Will EJ; Chinellato M; Bartling CRO; Strømgaard K; Cendron L; Angelini A; Heinis C
Angew Chem Int Ed Engl; 2024 Jun; 63(26):e202400350. PubMed ID: 38602024
[TBL] [Abstract][Full Text] [Related]
17. Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.
Buckton LK; Rahimi MN; McAlpine SR
Chemistry; 2021 Jan; 27(5):1487-1513. PubMed ID: 32875673
[TBL] [Abstract][Full Text] [Related]
18. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
Hess S; Ovadia O; Shalev DE; Senderovich H; Qadri B; Yehezkel T; Salitra Y; Sheynis T; Jelinek R; Gilon C; Hoffman A
J Med Chem; 2007 Nov; 50(24):6201-11. PubMed ID: 17983214
[TBL] [Abstract][Full Text] [Related]
19. Macrocycles as protein-protein interaction inhibitors.
Dougherty PG; Qian Z; Pei D
Biochem J; 2017 Mar; 474(7):1109-1125. PubMed ID: 28298556
[TBL] [Abstract][Full Text] [Related]
20. Hitting a Moving Target: How Does an N-Methyl Group Impact Biological Activity?
Koay YC; Richardson NL; Zaiter SS; Kho J; Nguyen SY; Tran DH; Lee KW; Buckton LK; McAlpine SR
ChemMedChem; 2016 Apr; 11(8):881-92. PubMed ID: 26805515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
